Hypercalcemia News

Osteoporosis Treatments Advanced by Mass Spectrometry Techniques - Technology Networks (blog)



Technology Networks (blog)
 
Osteoporosis Treatments Advanced by Mass Spectrometry Techniques 
Technology Networks (blog)
The use of current drugs that target this receptor?called vitamin D receptor agonists?is limited because use can result in hypercalcemia, a condition that can weaken bones and even cause kidney stones, due to too much calcium in the bloodstream.

and more » 


Hypercalcemia Treatment Market | Global Industry Trends, Analysis and Forecast 2017-2024 - Medgadget (blog)



Hypercalcemia Treatment Market | Global Industry Trends, Analysis and Forecast 2017-2024 
Medgadget (blog)
?Global Hypercalcemia Treatment Market? accounted to USD 76.9 billion in 2016 growing at a CAGR of 11.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 ...
Hypercalcemia Treatment Market foreseen to grow exponentially at 11.2% CAGR over 2026 The Global Health News (press release) (blog)

all 2 news articles » 


'Roadmap' to aid osteoporosis treatment development - Science Daily



'Roadmap' to aid osteoporosis treatment development 
Science Daily
The use of current drugs that target this receptor -- called vitamin D receptor agonists -- is limited because use can result in hypercalcemia, a condition that can weaken bones and even cause kidney stones, due to too much calcium in the bloodstream.

and more » 


Hypercalcemia Treatment Market Includes Important Growth Factor with Regional Forecast , Organization Sizes, Top ... - MilTech



Hypercalcemia Treatment Market Includes Important Growth Factor with Regional Forecast , Organization Sizes, Top ... 
MilTech
The Hypercalcemia Treatment Market report is to recognize, explain and forecast the global Hypercalcemia Treatment Market based on various aspects such as explanation, application, organization size, distribution mode, region. The Hypercalcemia ...

 


Global Hypercalcemia Treatment Market 2017 Expected Growth ... - MilTech



Global Hypercalcemia Treatment Market 2017 Expected Growth ... 
MilTech
Hypercalcemia Treatment Market report delivers a detailed study with present and upcoming Opportunities to clarify the future investment in the market. Global ...

and more » 


Distinct Phosphate Targets Feasible, Pilot Study Shows - Renal and Urology News



Renal and Urology News
 
Distinct Phosphate Targets Feasible, Pilot Study Shows 
Renal and Urology News
Excessive hyperphosphatemia above 7.75 mg/dL developed in 42% of the liberalized group and 3.8% of the intensive group. The investigators observed no differences in the risks for hypercalcemia, hypocalcemia, parathyroidectomy, or major vascular events ...

 


Hypercalcemia Treatment Market is Projected to Record at 11.2 ... - MilTech



Hypercalcemia Treatment Market is Projected to Record at 11.2 ... 
MilTech
The global hypercalcemia market is anticipated to register a CAGR of 11.2% in terms of revenue during forecast period 2016?2026, and reach a value of US$

and more » 


Here's a 'roadmap' to aid osteoporosis treatment - The Hans India - The Hans India



The Hans India
 
Here's a 'roadmap' to aid osteoporosis treatment - The Hans India 
The Hans India
Using advanced mass spectrometry technology, scientists have developed a molecular model that may provide a new framework for improving the design of ...

and more » 


Global Market for Hypercalcemia Treatment Is Projected to Reach ... - MilTech



Global Market for Hypercalcemia Treatment Is Projected to Reach ... 
MilTech
Global hypercalcemia treatment market revenues are anticipated to reach US$ 9.64 Bn in 2017, up from US$ 7.86 Bn in 2015. Increasing prevalence of.

and more » 


Hypercalcemia Treatment Market to Grow at CAGR of 5.44 ... - MilTech



Hypercalcemia Treatment Market to Grow at CAGR of 5.44 ... 
MilTech
Hypercalcemia Treatment market report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. The.

and more »